Semler Scientific (SMLR) Expected to Announce Earnings on Monday

Semler Scientific (NASDAQ:SMLR) will likely be releasing its Q2 2025 earnings data after the market closes on Monday, August 4th. Analysts expect Semler Scientific to post earnings of ($0.27) per share and revenue of $8.10 million for the quarter.

Semler Scientific (NASDAQ:SMLR) last issued its quarterly earnings results on Tuesday, May 13th. The company reported ($0.76) earnings per share (EPS) for the quarter. Semler Scientific had a negative net margin of 60.69% and a positive return on equity of 19.75%. The company had revenue of $8.84 million for the quarter.

Semler Scientific Trading Down 3.9%

Shares of Semler Scientific stock opened at $34.46 on Friday. The company has a current ratio of 0.52, a quick ratio of 0.51 and a debt-to-equity ratio of 0.59. Semler Scientific has a 12-month low of $21.77 and a 12-month high of $81.56. The firm has a market capitalization of $475.20 million, a price-to-earnings ratio of -13.20 and a beta of 1.34. The firm’s 50 day simple moving average is $38.02 and its two-hundred day simple moving average is $40.25.

Institutional Trading of Semler Scientific

Hedge funds have recently added to or reduced their stakes in the company. Royal Bank of Canada boosted its holdings in Semler Scientific by 101.2% during the first quarter. Royal Bank of Canada now owns 43,977 shares of the company’s stock worth $1,592,000 after buying an additional 22,123 shares in the last quarter. AQR Capital Management LLC boosted its holdings in Semler Scientific by 71.7% during the first quarter. AQR Capital Management LLC now owns 15,251 shares of the company’s stock worth $552,000 after buying an additional 6,371 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Semler Scientific by 47.1% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 3,965 shares of the company’s stock worth $144,000 after buying an additional 1,269 shares in the last quarter. 49.37% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on SMLR shares. Cantor Fitzgerald started coverage on shares of Semler Scientific in a research note on Monday. They set an “overweight” rating and a $61.00 price target on the stock. Wall Street Zen lowered shares of Semler Scientific from a “buy” rating to a “sell” rating in a research note on Thursday, May 22nd. Benchmark began coverage on shares of Semler Scientific in a research note on Tuesday, July 8th. They issued a “buy” rating and a $101.00 price objective on the stock. Finally, Maxim Group upgraded shares of Semler Scientific to a “strong-buy” rating and set a $95.00 price objective on the stock in a research note on Wednesday, July 9th. One investment analyst has rated the stock with a sell rating, three have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $82.00.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.